Biohaven Ltd. (NYSE:BHVN) shares dropped 16.19% in after-hours trading to $9.06 on Wednesday after the company reported that its Phase 2 depression drug trial missed its primary endpoint. Check out the current price of BHVN stock here. The stock closed regular session at $10.81, up 2.95%,…
Continue reading...